Furthermore, the promotion of autophagy and reduction of ER stress and hepatocyte apoptosis are mediated by SGLT-2, alleviating the progression of NAFLD (Nasiri-Ansari et al., 2021). Here, SLC5A2 is linked to metabolic dysfunction-associated steatotic liver disease.